{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:06:17Z","timestamp":1788861977291,"version":"build-2803163510"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL114832"],"award-info":[{"award-number":["R01 HL114832"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08HL102066 to DT"],"award-info":[{"award-number":["K08HL102066 to DT"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F31HL139093 to TAM"],"award-info":[{"award-number":["F31HL139093 to TAM"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["351960 to DT"],"award-info":[{"award-number":["351960 to DT"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.yjmcc.2019.01.013","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T21:38:41Z","timestamp":1547847521000},"page":"51-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Acute AT1R blockade prevents isoproterenol-induced injury in mdx hearts"],"prefix":"10.1016","volume":"128","author":[{"given":"Tatyana A.","family":"Meyers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie A.","family":"Heitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee M.","family":"Krebsbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Aufdembrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bartolomucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DeWayne","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2019.01.013_bb0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0015","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1161\/CIRCULATIONAHA.114.015151","article-title":"Contemporary cardiac issues in duchenne muscular dystrophy","volume":"131","author":"McNally","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mus.22097","article-title":"Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions","volume":"44","author":"Spurney","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0025","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00019052-200310000-00003","article-title":"Cardiomyopathy in muscular dystrophies","volume":"16","author":"Muntoni","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0030","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchene muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0040","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0896-6273(89)90226-2","article-title":"Dystrophin abnormalities in Duchenne\/Becker muscular dystrophy","volume":"2","author":"Hoffman","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0955-0674(05)80012-2","article-title":"Dystrophin and the membrane skeleton","volume":"5","author":"Campbell","year":"1993","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.biocel.2010.11.005","article-title":"Duchenne muscular dystrophy - what causes the increased membrane permeability in skeletal muscle?","volume":"43","author":"Allen","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7696(07)65005-0","article-title":"Biology of the striated muscle dystrophin-glycoprotein complex","volume":"265","author":"Ervasti","year":"2008","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.nurt.2008.08.013","article-title":"Approaching a new age in Duchenne muscular dystrophy treatment","volume":"5","author":"Wagner","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0065","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1096\/fj.06-7353com","article-title":"Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma","volume":"21","author":"Chamberlain","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0075","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0080","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/CIRCRESAHA.116.308402","article-title":"Duchenne muscular dystrophy mice and men: can understanding a genetic cardiomyopathy inform treatment of other myocardial diseases?","volume":"118","author":"Rafael-Fortney","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0085","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"Bulfield","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0090","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1002\/j.1460-2075.1988.tb03165.x","article-title":"Localization of the mdx mutation within the mouse dystrophin gene","volume":"7","author":"Ryder-Cook","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0100","doi-asserted-by":"crossref","first-page":"H303","DOI":"10.1152\/ajpheart.00485.2014","article-title":"Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart","volume":"308","author":"Meyers","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2261-11-20","article-title":"Membrane sealant poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice","volume":"11","author":"Spurney","year":"2011","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0110","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.111.031716","article-title":"Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice","volume":"124","author":"Rafael-Fortney","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0115","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/hmg\/ddh174","article-title":"Full-length dystrophin expression in half of the heart cells ameliorates \u03b2-isoproterenol-induced cardiomyopathy in mdx mice","volume":"13","author":"Yue","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0120","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.mt.6300144","article-title":"Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure","volume":"15","author":"Townsend","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0125","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1096\/fj.10-178913","article-title":"Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex","volume":"25","author":"Townsend","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0130","series-title":"Latent TGF-\u03b2 \u2013 Binding Protein 4 Modifies Muscular Dystrophy in Mice","volume":"vol. 119","author":"Heydemann","year":"2009"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0135","doi-asserted-by":"crossref","first-page":"10978","DOI":"10.1073\/pnas.1204708109","article-title":"Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-\u03b2 pathway","volume":"109","author":"Lorts","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0140","series-title":"Angiotensin II Type 1 Receptor Blockade Attenuates TGF- b \u2013 Induced Failure of Muscle Regeneration in Multiple Myopathic States","first-page":"204","volume":"vol. 13","author":"Cohn","year":"2007"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0145","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1152\/japplphysiol.01145.2006","article-title":"The role of free radicals in the pathophysiology of muscular dystrophy","volume":"102","author":"Tidball","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0150","first-page":"5167","article-title":"Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy","volume":"25","author":"Chadwick","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0155","doi-asserted-by":"crossref","first-page":"H1969","DOI":"10.1152\/ajpheart.00489.2007","article-title":"The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice","volume":"293","author":"Williams","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0160","article-title":"Double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in Duchenne muscular dystrophy","volume":"1","author":"Allen","year":"2013","journal-title":"PLoS Curr. Muscul. Dystrophy."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.amjcard.2012.02.064","article-title":"Effects of angiotensin-converting enzyme inhibitors and\/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy","volume":"110","author":"Viollet","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0170","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1113\/jphysiol.2007.148338","article-title":"N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice","volume":"586","author":"Whitehead","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0175","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.tcm.2017.12.006","article-title":"ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies","volume":"28","author":"Russo","year":"2018","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0180","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clnu.2012.06.001","article-title":"N-Acetylcysteine treatment reduces TNF-\u03b1 levels and myonecrosis in diaphragm muscle of mdx mice","volume":"32","author":"de Senzi Moraes Pinto","year":"2013","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lfs.2015.10.023","article-title":"Chronic effects of losartan on the muscles and the serologic profiles of mdx mice","volume":"143","author":"Lee","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0190","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coph.2017.04.002","article-title":"Pharmacological advances for treatment in Duchenne muscular dystrophy","volume":"34","author":"Guiraud","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0195","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.echo.2006.02.003","article-title":"Abnormalities of diastolic function precede dilated cardiomyopathy associated with Duchenne muscular dystrophy","volume":"19","author":"Markham","year":"2006","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev.med.58.011706.144703","article-title":"New approaches in the therapy of cardiomyopathy in muscular dystrophy","volume":"58","author":"McNally","year":"2007","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00246-004-0689-2","article-title":"Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies","volume":"26","author":"Kirchmann","year":"2005","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yjmcc.2014.08.013","article-title":"Dystrobrevin increases dystrophin's binding to the dystrophin-glycoprotein complex and provides protection during cardiac stress","volume":"76","author":"Strakova","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0215","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nature03844","article-title":"Dystrophic heart failure blocked by membrane sealant poloxamer","volume":"436","author":"Yasuda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.RES.36.1.185","article-title":"Dobutamine: Development of a new catecholamine to selectively increase cardiac contractility","volume":"36","author":"Tuttle","year":"1975","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0225","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/bja\/aeg116","article-title":"Acute heart failure during spinal surgery in a boy with Duchenne muscular dystrophy","volume":"90","author":"Schmidt","year":"2003","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0230","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1527-3466.1997.tb00327.x","article-title":"EXP3174: the major active metabolite of losartan","volume":"15","author":"Tamaki","year":"1997","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0235","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0009-9236(95)90020-9","article-title":"Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans","volume":"58","author":"Lo","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0240","author":"Team"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0245","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JND-170253","article-title":"Progression of duchenne cardiomyopathy presenting with chest pain and troponin elevation","volume":"4","author":"Hor","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0250","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.braindev.2007.01.009","article-title":"Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients","volume":"29","author":"Matsumura","year":"2007","journal-title":"Brain Dev."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0255","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1440-1754.2012.02428.x","article-title":"Evaluation of the North Star Ambulatory Assessment scale and cardiac abnormalities in ambulant boys with Duchenne muscular dystrophy","volume":"48","author":"Ergul","year":"2012","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0260","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00246-002-0408-9","article-title":"Myocardial cell damage in Duchenne muscular dystrophy","volume":"24","author":"Ramaciotti","year":"2003","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0265","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01002772","article-title":"Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections","volume":"11","author":"Junqueira","year":"1979","journal-title":"Histochem. J."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0270","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1369\/0022155414545787","article-title":"Picrosirius red staining: a useful tool to appraise collagen networks in normal and pathological tissues","volume":"62","author":"Lattouf","year":"2014","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0275","first-page":"97","article-title":"Collagen and picrosirius red staining\u202f: a polarized light assessment of fibrillar hue and spatial distribution","volume":"22","author":"Rich","year":"2005","journal-title":"Brazilian J. Morphol. Sci."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0280","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00495061","article-title":"The influence of tissue section thickness on the study of collagen by the picrosirius-polarization method","volume":"74","author":"Junqueira","year":"1982","journal-title":"Histochemistry"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0285","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00266843","article-title":"Are the polarization colors of picrosirius red-stained collagen determined only by the diameter of the fibers?","volume":"93","author":"Dayan","year":"1989","journal-title":"Histochemistry"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.immunol.21.120601.140946","article-title":"CD45: a critical regulator of signaling thresholds in immune cells","volume":"21","author":"Hermiston","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0295","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00066-014-0745-7","article-title":"Late inflammatory and thrombotic changes in irradiated hearts of C57BL\/6 wild-type and atherosclerosis-prone ApoE-deficient mice","volume":"191","author":"Patties","year":"2015","journal-title":"Strahlentherapie Und Onkol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0080908","article-title":"Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages","volume":"8","author":"Barros","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0305","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3389\/fimmu.2017.01097","article-title":"Regulation of human macrophage M1-M2 polarization balance by hypoxia and the triggering receptor expressed on Myeloid cells-1","volume":"8","author":"Raggi","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0310","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12885-015-1546-9","article-title":"M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide","volume":"15","author":"Genin","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0315","doi-asserted-by":"crossref","first-page":"965631","DOI":"10.1155\/2014\/965631","article-title":"Understanding the process of fibrosis in duchenne muscular dystrophy","volume":"2014","author":"Kharraz","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0320","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-\u03b21 and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0325","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/ars.2012.4604","article-title":"Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease","volume":"19","author":"Dikalov","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0330","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1074\/jbc.M708000200","article-title":"Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase","volume":"283","author":"Choi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0335","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/eurheartj\/ehv305","article-title":"Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications","volume":"36","author":"M\u00fcnzel","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0340","first-page":"22","article-title":"Use of Angiotensin receptor blockers in cardiovascular protection: current evidence and future directions","volume":"36","author":"Munger","year":"2011","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0345","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/hr.2010.67","article-title":"Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy","volume":"33","author":"Sukumaran","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0350","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drudis.2010.11.016","article-title":"Angiotensin II receptors and drug discovery in cardiovascular disease","volume":"16","author":"Dasgupta","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0355","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","article-title":"Fibrosis in heart disease: Understanding the role of transforming growth factor-\u03b21 in cardiomyopathy, valvular disease and arrhythmia","volume":"118","author":"Khan","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0360","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"Porter","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0365","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.yjmcc.2003.09.020","article-title":"Functional nitric oxide synthase mislocalization in cardiomyopathy","volume":"36","author":"Heydemann","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0370","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.23819","article-title":"LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy","volume":"73","author":"Flanigan","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0375","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00007.2015","article-title":"Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy","volume":"96","author":"Allen","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0380","doi-asserted-by":"crossref","first-page":"H710","DOI":"10.1152\/ajpheart.00890.2013","article-title":"NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy","volume":"307","author":"Gonzalez","year":"2014","journal-title":"AJP Hear. Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0385","doi-asserted-by":"crossref","first-page":"C634","DOI":"10.1152\/ajpcell.00372.2013","article-title":"Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase","volume":"307","author":"Cozzoli","year":"2014","journal-title":"AJP Cell Physiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0390","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1038\/s41467-018-07639-3","article-title":"Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle","volume":"9","author":"Olthoff","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0395","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0400","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.1202768","article-title":"X-ROS signaling\u202f: rapid mechano-chemo transduction in heart","volume":"333","author":"Prosser","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0405","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.yjmcc.2012.11.011","article-title":"X-ROS signaling in the heart and skeletal muscle: stretch-dependent local ROS regulates [Ca2+]i","volume":"58","author":"Prosser","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110708","article-title":"Diapocynin, a dimer of the NADPH oxidase inhibitor apocynin, reduces ROS production and prevents force loss in eccentrically contracting dystrophic muscle","volume":"9","author":"Ismail","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0415","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3892\/ijmm.2017.2856","article-title":"Renin-angiotensin system activation accelerates atherosclerosis in experimental renal failure by promoting endoplasmic reticulum stress-related inflammation","volume":"39","author":"Yang","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0420","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3389\/fphar.2018.01213","article-title":"Losartan alleviates renal fibrosis and inhibits endothelial-to-mesenchymal transition (EMT) under high-fat diet-induced hyperglycemia","volume":"9","author":"Yao","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0425","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/en.2010-1312","article-title":"Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice","volume":"152","author":"Fujisaka","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0430","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/ATVBAHA.111.237198","article-title":"Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis","volume":"31","author":"Yamamoto","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0435","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2015.06.018","article-title":"Novel players in cardioprotection: Insulin like growth factor-1, angiotensin-(1-7) and angiotensin-(1-9)","volume":"101","author":"Westermeier","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0440","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fendo.2013.00201","article-title":"Update on the angiotensin converting enzyme 2-angiotensin (1-7)-Mas receptor axis: fetal programing, sex differences, and intracellular pathways","volume":"4","author":"Chappell","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0445","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.113.01274","article-title":"Angiotensin-(1-7)","volume":"63","author":"Santos","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0450","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2016.11.064","article-title":"roles of angiotensin peptides and recombinant human ACE2 in heart failure","volume":"69","author":"Basu","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0455","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1373\/clinchem.2017.278705","article-title":"Low- and high-renin heart failure phenotypes with clinical implications","volume":"64","author":"Pavo","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0460","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/hr.2010.82","article-title":"Cardioprotective properties of bradykinin: role of the B2 receptor","volume":"33","author":"Manolis","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0465","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0003-4975(95)00192-N","article-title":"The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors","volume":"60","author":"Hartman","year":"1995","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0470","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1074248410381757","article-title":"Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice","volume":"16","author":"Spurney","year":"2011","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020856","article-title":"Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice","volume":"6","author":"Bish","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0480","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/eurjhf\/hfp028","article-title":"Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy","volume":"11","author":"Bauer","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0485","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12265-015-9623-7","article-title":"Absence of cardiac benefit with early combination ACE inhibitor and beta blocker treatment in mdx mice","volume":"8","author":"Blain","year":"2015","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0490","doi-asserted-by":"crossref","first-page":"e88360","DOI":"10.1371\/journal.pone.0088360","article-title":"Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of duchenne muscular dystrophy","volume":"9","author":"Janssen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0495","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"Duboc","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0500","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ahj.2007.05.014","article-title":"Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up","volume":"154","author":"Duboc","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0505","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mayocp.2015.10.019","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients without heart failure? Insights from 254,301 patients from randomized trials","volume":"91","author":"Bangalore","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.yjmcc.2019.01.013_bb0510","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the losartan heart failure survival study ELITE II","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818312604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818312604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T20:43:16Z","timestamp":1565210596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818312604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":102,"alternative-id":["S0022282818312604"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.01.013","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute AT1R blockade prevents isoproterenol-induced injury in mdx hearts","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}